Clinical-Legal Advisory for Health-AI Investment and Healthcare Compliance
Independent reads on clinical evidence, regulatory exposure, and post-Loper Bright enforcement risk for health-focused investors and operators.
Health-AI startups fail at the FDA, at the payer level, and in federal enforcement actions for reasons that aren't visible in the pitch deck. Clinical evidence claims that don't survive scrutiny. Billing models that create false-positive fraud exposure. Regulatory frameworks that shifted after Loper Bright in ways that change the compliance calculus entirely.
Dr Sonny Saggar MD provides independent clinical-legal reads for health-focused investors and operators who need someone who understands the evidence, the enforcement landscape, and the statutory framework simultaneously.
The credential: Oxford and Barts. 25 years emergency medicine. Published scholar with twelve papers on healthcare enforcement, administrative law post-Loper Bright, digital health standards, and open medical coding systems. Author of The Fifth Quadrant, The Architecture of Surrender, and The End of English as the Sole Language of Global Coordination, which frames the AI-era transformation of clinical data standards. Direct experience navigating federal healthcare enforcement as both defendant and scholar.
Schedule a Discovery CallEngagement Areas
Clinical Evidence Due Diligence
Rigorous verification of efficacy claims, patient outcome datasets, and algorithm accuracy assertions for Health-AI Series A through C venture rounds.
Regulatory & Enforcement Risk
Identifying diagnostic coding liability, billing design vulnerabilities, and documentation compliance gaps before regulatory inspection or fundraising.
Post-Loper Bright Architecture
Navigating the new boundaries of private credentialing board authority and federal compliance protocols in a post-Chevron administrative era.
Fee Structure
- Clinical Due Diligence Review From $3,500
- Monthly Advisory Retainer From $7,500 / mo
- Board Advisory Roles By Negotiation